Also its going to cut costs on sleep apnea and using devices
Likewise, the study of gut microbiota after treatment offers promising applications for therapy monitory or as biomarkers
Targeted agents like 5-HT4 agonists (tegaserod, prucalopride), guanylate cyclase-C agonists (linaclotide), and NHE3 inhibitors (tenapanor) modulate motility and pain signaling but face limitations such as side effects (e.g., diarrhea, cardiovascular risks) or insufficient long-term data
We recognize the potential of NAD+ injections to replenish these levels and counteract age-related decline
Ren W, Xia Y, Chen S, Wu G, Bazer FW, Zhou B, et al
One drink replaces your morning coffee and your post-workout shake